---
title: "Trientine - Renal cell carcinoma - 2"
sidebar: mydoc_sidebar
permalink: db06824-mesh-d002292-2.html
toc: false 
---


Path ID: `DB06824_MESH_D002292_2`
{% include image.html url="images/db06824-mesh-d002292-2.png" file="db06824-mesh-d002292-2.png" alt="db06824-mesh-d002292-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D014266 | Trientine | Drug |
| MESH:D003300 | Copper | ChemicalSubstance |
| InterPro:IPR000072 | Vascular endothelial growth factor-1 | GeneFamily |
| UniProt:P00441 | Superoxide dismutase 1 | Protein |
| UniProt:P19838 | Nuclear factor kappa-light-chain-enhancer of activated B cells | Protein |
| UniProt:P10145 | Interleukin 8 | Protein |
| InterPro:PR003573 | Interleukin 6 | GeneFamily |
| InterPro:IPR000975 | Interleukin 1 | GeneFamily |
| UniProt:P05230 | Fibroblast growth factor-1 | Protein |
| GO:0001525 | Angiogenesis | BiologicalProcess |
| CL:0001063 | Tumor cell | Cell |
| MESH:D002292 | Renal cell carcinoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Trientine | MOLECULARLY INTERACTS WITH | Copper |
| Copper | DECREASES ACTIVITY OF | Vascular Endothelial Growth Factor-1 |
| Vascular Endothelial Growth Factor-1 | NEGATIVELY REGULATES | Angiogenesis |
| Copper | DECREASES ACTIVITY OF | Fibroblast Growth Factor-1 |
| Fibroblast Growth Factor-1 | NEGATIVELY REGULATES | Angiogenesis |
| Copper | DECREASES ACTIVITY OF | Interleukin 1 |
| Interleukin 1 | NEGATIVELY REGULATES | Angiogenesis |
| Copper | DECREASES ACTIVITY OF | Interleukin 6 |
| Interleukin 6 | NEGATIVELY REGULATES | Angiogenesis |
| Copper | DECREASES ACTIVITY OF | Interleukin 8 |
| Interleukin 8 | NEGATIVELY REGULATES | Angiogenesis |
| Copper | DECREASES ACTIVITY OF | Nuclear Factor Kappa-Light-Chain-Enhancer Of Activated B Cells |
| Nuclear Factor Kappa-Light-Chain-Enhancer Of Activated B Cells | NEGATIVELY REGULATES | Angiogenesis |
| Copper | DECREASES ACTIVITY OF | Superoxide Dismutase 1 |
| Superoxide Dismutase 1 | NEGATIVELY REGULATES | Angiogenesis |
| Angiogenesis | LOCATED IN | Tumor Cell |
| Tumor Cell | CAUSES | Renal Cell Carcinoma |
|---------|-----------|---------|

Comment: Trientine is the salt form of Triethylenetetramine (DB06824)

Reference: 
  - [https://go.drugbank.com/drugs/DB06824#mechanismofaction](https://go.drugbank.com/drugs/DB06824#mechanismofaction)
  - DOI:10.1158/1535-7163.MCT-10-0523
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry](https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry)

Reference: 
  - [https://go.drugbank.com/drugs/DB06824#mechanismofaction](https://go.drugbank.com/drugs/DB06824#mechanismofaction)
  - DOI:10.1158/1535-7163.MCT-10-0523
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry](https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry)

Reference: 
  - [https://go.drugbank.com/drugs/DB06824#mechanismofaction](https://go.drugbank.com/drugs/DB06824#mechanismofaction)
  - DOI:10.1158/1535-7163.MCT-10-0523
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry](https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry)
